Article
Prognostic impact of pretreatment cytogenetics in adult P hiladelphia chromosome–negative acute lymphoblastic leukemia in the era of minimal residual disease
3 Oct 2016
Abstract excerpt
BACKGROUND: The introduction of novel prognostic factors such as minimal residual disease (MRD) and genomic profiling has led to the reevaluation of the role of cytogenetics and other conventional factors in risk stratification for acute lymphoblastic leukemia (ALL). METHODS: This study assessed the impact of baseline cytogenetics on the outcomes of 428 adult patients with Philadelphia chromosome-negative ALL who...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
